Alpha synuclein and Lrrk2 are key players in Parkinson's disease and related disorders, but their normal role has been confusing and controversial. Data from acute gene-editing based knockdown, followed by functional assays, will be presented.
We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.